1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies

Diamond Hill Capital Comments on Abbott Laboratories

January 15, 2014 | About:
Drug manufacturer Abbott Laboratories (ABT) reported revenue growth that was below expectations due to its exposure to the slower growth economies in Europe and the emerging markets. Despite the recent weakness, Abbott is a high-quality company with shares that we believe to be attractively priced. In addition, its management team has a strong record of investing capital prudently.

From Diamond Hill Capital (Trades, Portfolio) Large Cap Fund third quarter 2013 commentary.


Rating: 1.0/5 (2 votes)

Comments

Please leave your comment:


GuruFocus has detected 7 Warning Signs with Abbott Laboratories $ABT.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.

Performances of the stocks mentioned by


User Generated Screeners


pbarker46Cdn E & P
DANGORDONRETURN ON EQ 4-29-17
erilasDividendstrategie
HOLKLSUTake 5 Group Low Downside Cont
New MoonSmall Cap High ROIC
DANGORDONBOOK VAL GR 4-29-17
dvnrravinidhi_ev_ebitda
Roger SteraHEALTHY GROWTH
Roger SteraSmall Quality
Roger SteraEPS GROWTH 4-28-17
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK